Pharmacological inhibitors of IL-1β/IL-1 receptor signaling are efficacious in the treatment of some patients, supporting the hypothesis that pathophysiology of FMF is mediated in part by this cytokine [2]. The gene discussed is IL1B; the disease is familial Mediterranean fever.